Search

Your search keyword '"Bejjani, Antoine"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Bejjani, Antoine" Remove constraint Author: "Bejjani, Antoine"
41 results on '"Bejjani, Antoine"'

Search Results

1. Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19

2. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

3. Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism

4. Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods

5. Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study

6. Abstract 17709: ICD-10 Codes Have Low Sensitivity and Suboptimal Positive Predictive Value for Identifying Cases of Pulmonary Embolism With Cor Pulmonale in Electronic Healthcare Records

7. Abstract 17700: Double Trouble With Identification of Isolated Sub-Segmental Pulmonary Embolism Using ICD-10 Discharge Diagnosis Codes: The PE-EHR+ Study

8. Abstract 17282: Ninety-Day Thrombotic Events in Patients With COVID-19, Association With Vaccination Status, and Changes Over Time: The Corona-VTE Network Study

9. Abstract 17286: Ninety-Day Adjudicated Cardiovascular Events in Patients With Covid-19: Association With Vaccination Status and Changes Over Time in the Corona-VTE Network Study

10. Abstract 16342: Age- and Sex-Differences in Accuracy of ICD-10 Codes for Identifying Adults With Pulmonary Embolism: PE-EHR+ Study

11. Abstract 14344: Pitfalls of ICD-10 Codes for Identifying Pulmonary Embolism in Electronic Records: Results From the Multicenter PE-EHR+ Study

12. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review.

15. Abstract 12596: Comparison of the Efficacy and Safety of Direct Oral Anticoagulants With Vitamin K Antagonists in Patients With Thrombotic Antiphospholipid Syndrome: Systematic Review and Meta-analysis of Randomized Clinical Trials

18. Safety and Efficacy of Inferior Vena Cava Filters in Patients at Risk of Pulmonary Embolism: A Systematic Review and Meta-Analysis

19. Abstract 598: Patients With High Bleeding Risk In A Randomized Controlled Trial Of Alert-based Computerized Decision Support For Stroke Prevention In Atrial Fibrillation: An AF-ALERT II Substudy

20. Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2)

21. Abstract 379: The Accuracy Of ICD-10 Discharge Diagnosis Codes For Identification Of Isolated Sub-Segmental Pulmonary Embolism: A PE-EHR+ Substudy

22. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes Meta-Analysis of Randomized Trials

23. Right Ventricular Recovery: Early and Late Changes after Acute PE Diagnosis.

24. Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study

25. CRT-300.15 Safety and Efficacy of Inferior Vena Cava Filters in Patients at Risk of Pulmonary Embolism: A Systematic Review and Meta-Analysis

26. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes

27. Direct oral anticoagulants in thrombotic antiphospholipid syndrome: Addressing misinterpretations in subgroup analysis.

28. Monogenic and Polygenic Contributions to Venous Thromboembolism (VTE) and Splanchnic Thrombosis in Patients (pts) with Pancreatic Cancer (PC)

35. LOW ABSOLUTE RISK OF THROMBOTIC AND MAJOR CARDIOVASCULAR EVENTS IN OUTPATIENT PREGNANT WOMEN WITH COVID-19

36. ASSOCIATION BETWEEN INSURANCE STATUS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH COVID-19

37. ASSOCIATION BETWEEN OBESITY AND THE RISK OF THROMBOTIC AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH COVID-19

38. ADJUDICATED CARDIOVASCULAR EVENTS IN PATIENTS WITH COVID-19: ASSOCIATION WITH VACCINATION STATUS AND CHANGES OVER TIME IN THE CORONA-VTE NETWORK STUDY

39. OPTIMIZING PHENOTYPING ALGORITHMS FOR IDENTIFYING PULMONARY EMBOLISM IN ELECTRONIC DATABASES: THE MULTICENTER PE-EHR+ STUDY

40. Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials.

41. Direct Oral Anticoagulants: Quick Primer on When to Use and When to Avoid.

Catalog

Books, media, physical & digital resources